Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Marsoni

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Science Translational Medicine|May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancerElena Grassi, Valentina Vurchio, George D Cresswell, et al.
The Lancet. Oncology|April 25, 2016
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trialAndrea Sartore-Bianchi, Livio Trusolino, Cosimo Martino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2015
Assessment of a HER2 scoring system for colorectal cancer: results from a validation studyEmanuele Valtorta, Cosimo Martino, Andrea Sartore-Bianchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Nature Medicine|July 8, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for <i>MGMT</i> Gene Promoter Hypermethylation DetectionMarco Macagno, Valeria Pessei, Noemi Congiusta, et al.
Cancer Discovery|May 21, 2020
EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal CancerVito Amodio, Rona Yaeger, Pamela Arcella, et al.
Nature Medicine|June 2, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Cancer Cell|April 2, 2021
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liverAlice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Science Translational Medicine|May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancerElena Grassi, Valentina Vurchio, George D Cresswell, et al.
The Lancet. Oncology|April 25, 2016
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trialAndrea Sartore-Bianchi, Livio Trusolino, Cosimo Martino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2015
Assessment of a HER2 scoring system for colorectal cancer: results from a validation studyEmanuele Valtorta, Cosimo Martino, Andrea Sartore-Bianchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Nature Medicine|July 8, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for <i>MGMT</i> Gene Promoter Hypermethylation DetectionMarco Macagno, Valeria Pessei, Noemi Congiusta, et al.
Cancer Discovery|May 21, 2020
EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal CancerVito Amodio, Rona Yaeger, Pamela Arcella, et al.
Nature Medicine|June 2, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Cancer Cell|April 2, 2021
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liverAlice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Pageof 9